{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:31:39Z","timestamp":1774294299429,"version":"3.50.1"},"reference-count":145,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2019,7,12]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Medications currently available for the management of diabetes mellitus are inconvenient and have some limitations. Thus, investigations for novel approaches are needed to deliver and target antidiabetics safely to the site of action.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The present review emphasizes the limitations of conventional antidiabetics and provides the recent progresses of nanotechnology in the treatment of diabetes mellitus with a special highlight on the novel nanocarriers methodologies employed as antidiabetic drug delivery systems.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The potential nanocarriers employed for the treatment of diabetes comprise liposomes, niosomes, self-nanoemulsifying drug delivery systems, polymeric nanoparticles, gold nanoparticles, dendrimers and micelles. Herbal nanomedicine has also emerged to be a promising way for adequate delivery of herbal compounds. Other nanotechnology approaches involve the usage of oral insulin, inhalable insulin, artificial pancreas, and nanopump.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Nanocarriers have proved to lead a successful delivery of antidiabetic medications, aiming at drug targeting for enhanced efficacy and safety.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>These innovative generations of drug delivery systems have important benefits over conventionally existing ones. The future of nanotechnology in the management of diabetes is still open with several prospects and will be of pronounced significance.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389450120666190307101642","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:33:12Z","timestamp":1552044792000},"page":"995-1007","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus"],"prefix":"10.2174","volume":"20","author":[{"given":"Amira Mohamed","family":"Mohsen","sequence":"first","affiliation":[{"name":"Pharmaceutical Technology Department, National Research Centre, Dokki 12622, Giza, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrd4477","volume":"14","author":"Veiseh O.","year":"2015","unstructured":"Veiseh O, Tang BC, Whitehead KA, Anderson DG, Langer R. Managing diabetes with nanomedicine: challenges and opportunities.","journal-title":"Nat Rev Drug Discov"},{"key":"ref=2","first-page":"221","volume":"3","author":"Arya A.K.","year":"2008","unstructured":"Arya AK, Kumar L, Pokharia D, Tripathi K. Applications of nano- technology in diabetes.","journal-title":"Dig J Nanomater Biostruct"},{"key":"ref=3","first-page":"74","volume":"8","author":"Li W.","year":"2017","unstructured":"Li W, Yuan G, Pan Y, Wang C, Chen H. Network pharmacology studies on the bioactive compounds and action mechanisms of natural products for the treatment of diabetes mellitus: A review.","journal-title":"Front Pharmacol"},{"key":"ref=4","first-page":"C14","volume":"22","author":"Sowers J.R.","year":"1999","unstructured":"Sowers JR, Lester MA. Diabetes and cardiovascular disease.","journal-title":"Diabetes Care"},{"key":"ref=5","author":"Tierney L.","year":"2002","unstructured":"Tierney L.","journal-title":"Current medical diagnosis and treatment"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"Alberti K.G.M.M.","year":"1998","unstructured":"Alberti KGMM, Zimmet Pf. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation.","journal-title":"Diabet Med"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","volume":"28","author":"Group N.D.D.","year":"1979","unstructured":"Group NDD. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.","journal-title":"Diabetes"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/cr0204653","volume":"104","author":"Ross S.A.","year":"2004","unstructured":"Ross SA, Gulve EA, Wang M. Chemistry and biochemistry of type 2 diabetes.","journal-title":"Chem Rev"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1039\/c3cs60436e","volume":"43","author":"Mo R.","year":"2014","unstructured":"Mo R, Jiang T, Di J, Tai W, Gu Z. Emerging micro-and nanotechnology based synthetic approaches for insulin delivery.","journal-title":"Chem Soc Rev"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3109\/10717544.2014.991001","volume":"23","author":"Rai V.K.","year":"2016","unstructured":"Rai VK, Mishra N, Agrawal AK, Jain S, Yadav NP. Novel drug delivery system: an immense hope for diabetics.","journal-title":"Drug Deliv"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/diaclin.30.2.44","volume":"30","author":"Rotenstein L.S.","year":"2012","unstructured":"Rotenstein LS, Kozak BM, Shivers JP. The ideal diabetes therapy: what will it look like? How close are we?","journal-title":"Clin Diabetes"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1021\/cr5002832","volume":"115","author":"Kokil G.R.","year":"2015","unstructured":"Kokil GR, Veedu RN, Ramm GA, Prins JB, Parekh HS. Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics.","journal-title":"Chem Rev"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2014.903579","volume":"23","author":"Sutradhar K.B.","year":"2016","unstructured":"Sutradhar KB, Sumi CD. Implantable microchip: the futuristic controlled drug delivery system.","journal-title":"Drug Deliv"},{"key":"ref=14","first-page":"243","volume":"1","author":"Pradhan S.K.","year":"2011","unstructured":"Pradhan SK. Microsponges as the versatile tool for drug delivery system.","journal-title":"Int J Res Pharm Chem"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0169-409X(95)00019-4","volume":"18","author":"Schmid M-H.","year":"1996","unstructured":"Schmid M-H, Korting H. Therapeutic progress with topical liposome drugs for skin disease.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2017.11.018","volume":"136","author":"Kesharwani P.","year":"2017","unstructured":"Kesharwani P, Gorain B, Low SY. Nanotechnology based approaches for anti-diabetic drugs delivery.","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/sj.embor.7400017","volume":"4","author":"Kralj M.","year":"2003","unstructured":"Kralj M, Pavelic K. Medicine on a small scale.","journal-title":"EMBO Rep"},{"key":"ref=18","first-page":"7","volume":"10","author":"Logothetidis S.","year":"2006","unstructured":"Logothetidis S. Nanotechnology in medicine: the medicine of tomorrow and nanomedicine.","journal-title":"Hippokratia"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/dmrr.893","volume":"24","author":"Pickup J.C.","year":"2008","unstructured":"Pickup JC, Zhi ZL, Khan F, Saxl T, Birch DJ. Nanomedicine and its potential in diabetes research and practice.","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/adhm.201200037","volume":"1","author":"Bratlie K.M.","year":"2012","unstructured":"Bratlie KM, York RL, Invernale MA, Langer R, Anderson DG. Materials for diabetes therapeutics.","journal-title":"Adv Healthc Mater"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1021\/nl5012504","volume":"14","author":"Yetisen A.K.","year":"2014","unstructured":"Yetisen AK, Montelongo Y, da Cruz Vasconcellos F. Reusable, robust, and accurate laser-generated photonic nanosensor.","journal-title":"Nano Lett"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bios.2010.08.052","volume":"26","author":"Veetil J.V.","year":"2010","unstructured":"Veetil JV, Jin S, Ye K. A glucose sensor protein for continuous glucose monitoring.","journal-title":"Biosens Bioelectron"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.08.009","volume":"132","author":"Ravaine V.","year":"2008","unstructured":"Ravaine V, Ancla C, Catargi B. Chemically controlled closed-loop insulin delivery.","journal-title":"J Control Release"},{"key":"ref=24","volume":"3","author":"Harsoliya M.","year":"2012","unstructured":"Harsoliya M. Recent advances","journal-title":"Int J Pharm Biol Arch"},{"key":"ref=25","first-page":"1","volume":"3","author":"Rajalakshmi A.","year":"2014","unstructured":"Rajalakshmi A. Impact of nanotechnology in diabetes.","journal-title":"Bull Env Pharmacol Life Sci"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2155-952X.1000268","volume":"7","author":"Gupta R.","year":"2017","unstructured":"Gupta R. Diabetes treatment by nanotechnology.","journal-title":"J Biotechnol Biomater"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G","volume":"57","author":"Desai T.A.","year":"1998","unstructured":"Desai TA, Chu WH, Tu JK. Microfabricated immunoisolating biocapsules.","journal-title":"Biotechnol Bioeng"},{"key":"ref=28","first-page":"45","volume":"80","author":"Freitas R.A.","year":"2002","unstructured":"Freitas RA. The future of nanofabrication and molecular scale devices in nanomedicine.","journal-title":"Stud Health Technol Inform"},{"key":"ref=29","first-page":"966","volume":"25","author":"Wu Z-H.","year":"2004","unstructured":"Wu Z-H, Ping Q-N, Wei Y, Lai J. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.","journal-title":"Acta Pharmacol Sin"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.xphs.2018.04.011","volume":"107","author":"Shalaby T.I.","year":"2018","unstructured":"Shalaby TI, El-Refaie WM. Bioadhesive chitosan-coated cationic nanoliposomes with improved insulin encapsulation and prolonged oral hypoglycemic effect in diabetic mice.","journal-title":"J Pharm Sci"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2217\/nnm.11.116","volume":"6","author":"Niu M.","year":"2011","unstructured":"Niu M, Lu Y, Hovgaard L, Wu W. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, characterization, and improved protection against enzymatic degradation.","journal-title":"Int J Nanomedicine"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","volume":"81","author":"Niu M.","year":"2012","unstructured":"Niu M, Lu Y, Hovgaard L. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijpharm.2012.10.025","volume":"441","author":"Hu S.","year":"2013","unstructured":"Hu S, Niu M, Hu F. Integrity and stability of oral liposomes containing bile salts studied in simulated and gastrointestinal media.","journal-title":"Int J Pharm"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1556-276X-9-185","volume":"9","author":"Zhang X.","year":"2014","unstructured":"Zhang X, Qi J, Lu Y. Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity.","journal-title":"Nanoscale Res Lett"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nano.2013.07.011","volume":"10","author":"Zhang X.","year":"2014","unstructured":"Zhang X, Qi J, Lu Y. Biotinylated liposomes as potential carriers for the oral delivery of insulin.","journal-title":"Nanomed Nanotechnol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.msec.2014.10.070","volume":"46","author":"Moghassemi S.","year":"2015","unstructured":"Moghassemi S, Parnian E, Hakamivala A. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes.","journal-title":"Mater Sci Eng C"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpharm.2006.08.002","volume":"328","author":"Pardakhty A.","year":"2007","unstructured":"Pardakhty A, Varshosaz J, Rouholamini A. study of polyoxy- ethylene alkyl ether niosomes for delivery of insulin.","journal-title":"Int J Pharm"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540590968891","volume":"12","author":"Ning M.","year":"2005","unstructured":"Ning M, Guo Y, Pan H, Yu H, Gu Z. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats.","journal-title":"Drug Deliv"},{"key":"ref=39","first-page":"743","volume":"2","author":"Sarmento B.","year":"2007","unstructured":"Sarmento B, Martins S, Ferreira D, Souto EB. Oral insulin delivery by means of solid lipid nanoparticles.","journal-title":"Int J Nanomedicine"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13346-011-0023-5","volume":"1","author":"Fonte P.","year":"2011","unstructured":"Fonte P, Nogueira T, Gehm C, Ferreira D, Sarmento B. Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin.","journal-title":"Drug Deliv Transl Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/nn400630x","volume":"7","author":"Gu Z.","year":"2013","unstructured":"Gu Z, Aimetti AA, Wang Q. Injectable nano-network for glucose-mediated insulin delivery.","journal-title":"ACS Nano"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2016.05.015","volume":"233","author":"Sheng J.","year":"2016","unstructured":"Sheng J, He H, Han L. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.","journal-title":"J Control Release"},{"key":"ref=43","first-page":"2207","volume":"10","author":"Malathi S.","year":"2015","unstructured":"Malathi S, Nandhakumar P, Pandiyan V, Webster TJ, Balasubramanian S. Novel PLGA-based nanoparticles for the oral delivery of insulin.","journal-title":"Int J Nanomedicine"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/j.jconrel.2015.05.206","volume":"213","author":"Li X.","year":"2015","unstructured":"Li X, Wu W, Li J. Glucose-responsive micelles for insulin release.","journal-title":"J Control Release"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/jps.22428","volume":"100","author":"Dong Z.","year":"2011","unstructured":"Dong Z, Hamid KA, Gao Y. Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats.","journal-title":"J Pharm Sci"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijbiomac.2015.10.029","volume":"82","author":"Nowacka O.","year":"2016","unstructured":"Nowacka O, Milowska K, Belica-Pacha S. Generation-dependent effect of PAMAM dendrimers on human insulin fibrillation and thermal stability.","journal-title":"Int J Biol Macromol"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.colsurfb.2014.01.056","volume":"116","author":"Nowacka O.","year":"2014","unstructured":"Nowacka O, Shcharbin D, Klajnert-Maculewicz B, Bryszewska M. Stabilizing effect of small concentrations of PAMAM dendrimers at the insulin aggregation.","journal-title":"Colloids Surf B"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biomaterials.2015.11.007","volume":"77","author":"Fang X.","year":"2016","unstructured":"Fang X, Yang T, Wang L. Nano-cage-mediated refolding of insulin by PEG-PE micelle.","journal-title":"Biomaterials"},{"key":"ref=49","first-page":"22","volume":"8","author":"Subash Chandran M.","year":"2016","unstructured":"Subash Chandran M, Pandey V. and evaluation of glimepiride loaded liposomes.","journal-title":"Der Pharma Chem"},{"key":"ref=50","first-page":"1","author":"Mohsen A.M.","year":"2017","unstructured":"Mohsen AM, AbouSamra MM, ElShebiney SA. Enhanced oral bioavailability and sustained delivery of glimepiride niosomal encapsulation: characterization and evaluation.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/10717544.2013.879753","volume":"22","author":"Mohd A.B.","year":"2015","unstructured":"Mohd AB, Sanka K, Bandi S, Diwan PV, Shastri N. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits.","journal-title":"Drug Deliv"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0975-1483.57065","volume":"1","author":"Tamizharasi S.","year":"2009","unstructured":"Tamizharasi S, Dubey A, Rathi V, Rathi J. Development and characterization of niosomal drug delivery of gliclazide.","journal-title":"J Young Pharm"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jsps.2015.01.024","volume":"23","author":"Dash R.N.","year":"2015","unstructured":"Dash RN, Mohammed H, Humaira T, Ramesh D. Design, optimization and evaluation of glipizide solid self-nanoemulsifying drug delivery for enhanced solubility and dissolution.","journal-title":"Saudi Pharm J"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.colsurfb.2014.07.022","volume":"122","author":"Karthick V.","year":"2014","unstructured":"Karthick V, Kumar VG, Dhas TS. Effect of biologically synthesized gold nanoparticles on alloxan-induced diabetic rats-an approach.","journal-title":"Colloids Surf B"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.biopha.2016.07.052","volume":"83","author":"Shaheen T.I.","year":"2016","unstructured":"Shaheen TI, El-Naggar ME, Hussein JS. Antidiabetic assessment; study of gold and core-shell silver-gold nanoparticles on streptozotocin-induced diabetic rats.","journal-title":"Biomed Pharmacother"},{"key":"ref=56","first-page":"285","volume":"5","author":"Pandita D.","year":"2017","unstructured":"Pandita D, Kumari N, Lather V. A Self-nanoemulsifying Drug delivery system for poorly water soluble tolbutamide: development, optimization and pharmacodynamic studies.","journal-title":"Pharm Nanotechnol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.37285\/ijpsn.2015.8.1.8","volume":"8","author":"Namdev S.","year":"2015","unstructured":"Namdev S, Gujar K, Mandlik S, Jamkar P. Preparation and characterization of niosomal carriers of the antidiabetic drug repaglinide.","journal-title":"IJPSN"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40199-015-0128-3","volume":"23","author":"Ebrahimi H.A.","year":"2015","unstructured":"Ebrahimi HA, Javadzadeh Y, Hamidi M, Jalali MB. Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants\/stabilizers on physicochemical properties of nanoparticles.","journal-title":"DARU J Pharm Sci"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejps.2016.12.005","volume":"99","author":"Kassem A.","year":"2017","unstructured":"Kassem A. SH AE-A, Basha M, Salama A. Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide.","journal-title":"Eur J Pharm Sci"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1166\/jpsp.2015.1042","volume":"2","author":"Haider M.","year":"2015","unstructured":"Haider M, Kanoujia J, Tripathi CB. Pioglitazone loaded vesicular carriers for anti-diabetic activity: development and optimization as per central composite design.","journal-title":"J Pharm Sci Pharmacol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1208\/s12249-013-9926-4","volume":"14","author":"Manconi M.","year":"2013","unstructured":"Manconi M, N\u00e1cher A, Merino V. Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate\u2013chitosan microcomplexation.","journal-title":"AAPS PharmSciTech"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2008-2231-21-7","volume":"21","author":"Sankhyan A.","year":"2013","unstructured":"Sankhyan A, Pawar PK. Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization.","journal-title":"DARU J Pharm Sci"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/10717544.2013.779332","volume":"20","author":"Hasan A.A.","year":"2013","unstructured":"Hasan AA, Madkor H, Wageh S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.","journal-title":"Drug Deliv"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/03639045.2015.1075028","volume":"42","author":"Xu Q.","year":"2016","unstructured":"Xu Q, Zhu T, Yi C, Shen Q. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"Akbarzadeh A.","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S. Liposome: classification, preparation, and applications.","journal-title":"Nanoscale Res Lett"},{"key":"ref=66","first-page":"1","volume":"55","author":"Goyal P.","year":"2005","unstructured":"Goyal P, Goyal K, Kumar SGV. Liposomal drug delivery systems-clinical applications.","journal-title":"Acta Pharm"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1080\/03639045.2017.1361968","volume":"43","author":"Mohsen A.M.","year":"2017","unstructured":"Mohsen AM, Asfour MH, Salama AA. Improved hepatoprotective activity of silymarin encapsulation in the novel vesicular nanosystem bilosomes.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1172\/JCI965","volume":"101","author":"Thurston G.","year":"1998","unstructured":"Thurston G, McLean JW, Rizen M. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.","journal-title":"J Clin Invest"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcis.2008.01.025","volume":"320","author":"Lim H.J.","year":"2008","unstructured":"Lim HJ, Cho EC, Shim J. Polymer-associated liposomes as a novel delivery system for cyclodextrin-bound drugs.","journal-title":"J Colloid Interface Sci"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bm401580k","volume":"15","author":"Agrawal A.K.","year":"2013","unstructured":"Agrawal AK, Harde H, Thanki K, Jain S. Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.","journal-title":"Biomacromol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40005-016-0249-9","volume":"46","author":"Khan R.","year":"2016","unstructured":"Khan R, Irchhaiya R. Niosomes: a potential tool for novel drug delivery.","journal-title":"J Pharm Investig"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0001-8686(95)00242-I","volume":"58","author":"Uchegbu I.F.","year":"1995","unstructured":"Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry.","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=73","first-page":"122","volume":"15","author":"El-Ridy M.S.","year":"2018","unstructured":"El-Ridy MS, Yehia SA, Mohsen AM, El-Awdan SA, Darwish AB. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: and Evaluation.","journal-title":"Curr Drug Deliv"},{"key":"ref=74","first-page":"549","volume":"4","author":"El-Ridy M.S.","year":"2012","unstructured":"El-Ridy MS, Badawi AA, Safar MM, Mohsen AM. Niosomes as a novel pharmaceutical formulation encapsulating the hepatoprotective drug silymarin.","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=75","volume":"2","author":"Lohumi A.","year":"2012","unstructured":"Lohumi A. A novel drug delivery system: niosomes review.","journal-title":"J Drug Deliv Ther"},{"key":"ref=76","first-page":"498","volume":"1","author":"","year":"2011","unstructured":". NVS M, Saini A. Niosomes: a novel drug delivery system.","journal-title":"Int J Res Pharm Chem"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4103\/0110-5558.76435","volume":"1","author":"Kazi K.M.","year":"2010","unstructured":"Kazi KM, Mandal AS, Biswas N. Niosome: a future of targeted drug delivery systems.","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/2230-973X.107002","volume":"2","author":"Shirsand S.","year":"2012","unstructured":"Shirsand S, Para M, Nagendrakumar D, Kanani K, Keerthy D. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system.","journal-title":"Int J Pharm Investig"},{"key":"ref=79","first-page":"394","volume":"2","author":"Chandra S.","year":"2011","unstructured":"Chandra S, Venu V, Jaganathan K, Perumal P. Formulation and evaluation of sustained release matrix tablets of glimepiride by using natural gums as release modifiers.","journal-title":"J Glob Trends Pharm Sci"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10611860903079454","volume":"17","author":"Azeem A.","year":"2009","unstructured":"Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances.","journal-title":"J Drug Target"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3109\/10717544.2014.942811","volume":"23","author":"ElMeshad A.N.","year":"2016","unstructured":"ElMeshad AN, Mohsen AM. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans a novel nanosystem vesicle.","journal-title":"Drug Deliv"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.biopha.2017.11.073","volume":"97","author":"Alam M.S.","year":"2018","unstructured":"Alam MS, Ahad A, Abidin L. Embelin-loaded oral niosomes ameliorate streptozotocin-induced diabetes in Wistar rats.","journal-title":"Biomed Pharmacother"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/08982104.2017.1343835","volume":"28","author":"Sultan A.A.","year":"2018","unstructured":"Sultan AA, El-Gizawy SA, Osman MA, El Maghraby GM. Niosomes for oral delivery of nateglinide: correlation.","journal-title":"J Liposome Res"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.colsurfb.2012.07.017","volume":"101","author":"Singh B.","year":"2013","unstructured":"Singh B, Singh R, Bandyopadhyay S, Kapil R, Garg B. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol.","journal-title":"Colloids Surf B"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.addr.2007.10.014","volume":"60","author":"Porter C.J.","year":"2008","unstructured":"Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2012.07.055","volume":"438","author":"Hu X.","year":"2012","unstructured":"Hu X, Lin C, Chen D. Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation.","journal-title":"Int J Pharm"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejpb.2010.07.011","volume":"76","author":"Setthacheewakul S.","year":"2010","unstructured":"Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1023\/A:1016268311867","volume":"12","author":"Constantinides P.P.","year":"1995","unstructured":"Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.","journal-title":"Pharm Res"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.colsurfb.2013.08.025","volume":"112","author":"Balakumar K.","year":"2013","unstructured":"Balakumar K, Raghavan CV, Abdu S. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation.","journal-title":"Colloids Surf B"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molliq.2016.02.081","volume":"218","author":"Kassem A.A.","year":"2016","unstructured":"Kassem AA, Mohsen AM, Ahmed RS, Essam TM. Self-nanoemulsi- fying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: Design, optimization, and evaluation.","journal-title":"J Mol Liq"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-409X(96)00490-5","volume":"25","author":"Pouton C.W.","year":"1997","unstructured":"Pouton CW. Formulation of self-emulsifying drug delivery systems.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijpharm.2006.08.038","volume":"329","author":"Date A.A.","year":"2007","unstructured":"Date AA, Nagarsenker M. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil.","journal-title":"Int J Pharm"},{"key":"ref=93","doi-asserted-by":"crossref","unstructured":"Mat Sci Res India 2018; 15(1): 01- 11.","DOI":"10.13005\/msri\/150101"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.carbpol.2016.11.027","volume":"157","author":"Wu D-Y.","year":"2017","unstructured":"Wu D-Y, Ma Y, Hou X-S. Co-delivery of antineoplastic and protein drugs by chitosan nanocapsules for a collaborative tumor treatment.","journal-title":"Carbohydr Polym"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","volume":"64","author":"Wilczewska A.Z.","year":"2012","unstructured":"Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. Nano- particles as drug delivery systems.","journal-title":"Pharmacol Rep"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.addr.2008.09.001","volume":"60","author":"Liu Z.","year":"2008","unstructured":"Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"380","DOI":"10.22159\/ijpps.2016v8i11.14365","volume":"8","author":"Abousamra Mm.","year":"2016","unstructured":"Abousamra Mm, Mohsen Am. Solid lipid nanoparticles and nanostructured lipid carriers of tolnaftate: design, optimization and evaluation.","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jare.2017.10.003","volume":"9","author":"Asfour M.H.","year":"2018","unstructured":"Asfour MH, Mohsen AM. Formulation and evaluation of pH-sensitive rutin nanospheres against colon carcinoma using HCT-116 cell line.","journal-title":"J Adv Res"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"De Jong W.H.","year":"2008","unstructured":"De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards.","journal-title":"Int J Nanomedicine"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-60761-609-2_11","author":"Chan J.M.","year":"2010","unstructured":"Chan JM, Valencia PM, Zhang L, Langer R, Farokhzad OC. Polymeric nanoparticles for drug delivery.","journal-title":"Cancer Nanotechnol"},{"key":"ref=101","volume":"5","author":"Sona P.","year":"2010","unstructured":"Sona P. Nanoparticulate drug delivery systems for the treatment of diabetes.","journal-title":"Dig J Nanomater Biostruct"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/17425247.2018.1420050","volume":"15","author":"Sgorla D.","year":"2018","unstructured":"Sgorla D, Lechanteur A, Almeida A. Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery.","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/ja908117a","volume":"132","author":"Brown S.D.","year":"2010","unstructured":"Brown SD, Nativo P, Smith J-A. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin.","journal-title":"J Am Chem Soc"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0031-6989(81)80074-4","volume":"13","author":"Shanmugasundaram K.R.","year":"1981","unstructured":"Shanmugasundaram KR, Panneerselvam C, Samudram P, Shanmugasundaram E. The insulinotropic activity of Gymnema sylvestre, R. Br. An Indian medical herb used in controlling diabetes mellitus.","journal-title":"Pharmacol Res Commun"},{"key":"ref=105","first-page":"16","volume":"6","author":"Edrees H.M.","year":"2017","unstructured":"Edrees HM, Elbehiry A, Elmosaad YM. Hypoglycemic and anti-inflammatory effect of gold nanoparticles in streptozotocin-induced type 1 diabetes in experimental rats.","journal-title":"Int J Diabetes Res"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.etap.2017.01.007","volume":"50","author":"Sengani M.","year":"2017","unstructured":"Sengani M. Identification of potential antioxidant indices by biogenic gold nanoparticles in hyperglycemic Wistar rats. \u200e.","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","volume":"9","author":"Abbasi E.","year":"2014","unstructured":"Abbasi E, Aval SF, Akbarzadeh A. Dendrimers: synthesis, applications, and properties.","journal-title":"Nanoscale Res Lett"},{"key":"ref=108","first-page":"44","volume":"2015","author":"Baig T.","year":"2015","unstructured":"Baig T, Nayak J, Dwivedi V. A review about dendrimers: Synthesis, types, characterization and applications.","journal-title":"Int J Adv Pharm Biol Chem"},{"key":"ref=109","unstructured":"Dendrimers: Novel carriers for drug delivery. JAPTRonline 2016; 4(1): 01-19."},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/09205063.2015.1133155","volume":"27","author":"Dwivedi N.","year":"2016","unstructured":"Dwivedi N, Shah J, Mishra V. Dendrimer-mediated approaches for the treatment of brain tumor.","journal-title":"J Biomater Sci Polym Ed"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.drudis.2016.12.007","volume":"22","author":"Gorain B.","year":"2017","unstructured":"Gorain B, Tekade M, Kesharwani P. The use of nanoscaffolds and dendrimers in tissue engineering.","journal-title":"Drug Discov Today"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nano.2006.04.002","volume":"2","author":"Gupta U.","year":"2006","unstructured":"Gupta U, Agashe HB, Asthana A, Jain NK. A review of investigations on dendrimers: the novel nanoscopic drug carriers.","journal-title":"Nanomed Nanotechnol"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejpb.2014.12.023","volume":"95","author":"Fangueiro J.F.","year":"2015","unstructured":"Fangueiro JF, Silva AM, Garcia ML, Souto EB. Current nanotechnology approaches for the treatment and management of diabetic retinopathy.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1367-5931(02)00400-3","volume":"6","author":"Cloninger M.J.","year":"2002","unstructured":"Cloninger MJ. Biological applications of dendrimers.","journal-title":"Curr Opin Chem Biol"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0939-6411(99)00039-9","volume":"48","author":"Jones M-C.","year":"1999","unstructured":"Jones M-C, Leroux J-C. Polymeric micelles-a new generation of colloidal drug carriers.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1039\/C3RA47370H","volume":"4","author":"Ahmad Z.","year":"2014","unstructured":"Ahmad Z, Shah A, Siddiq M, Kraatz H-B. Polymeric micelles as drug delivery vehicles.","journal-title":"Rsc Adv"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1021\/acs.chemmater.6b02965","volume":"28","author":"Liao C.","year":"2016","unstructured":"Liao C, Chen Y, Yao Y. Cross-linked small-molecule micelle-based drug delivery system: concept, synthesis, and biological evaluation.","journal-title":"Chem Mater"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biomaterials.2006.11.039","volume":"28","author":"Seow W.Y.","year":"2007","unstructured":"Seow WY, Xue JM, Yang Y-Y. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles.","journal-title":"Biomaterials"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2217\/nnm-2016-0045","volume":"11","author":"Andrade F.","year":"2016","unstructured":"Andrade F, Fonte P, Costa A. Pharmacological and toxicological assessment of innovative self-assembled polymeric micelles as powders for insulin pulmonary delivery.","journal-title":"Nanomedicine"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2155-983X.1000143","volume":"6","author":"Gopi S.","year":"2016","unstructured":"Gopi S, Amalraj A, Haponiuk J, Thomas S. Introduction of nanotechnology in herbal drugs and nutraceutical: A Review.","journal-title":"J Nanomedine Biotherapeutic Discov"},{"key":"ref=121","unstructured":"The world health report 2008: primary health care: now more than ever: World Health Organization; 2008."},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cbi.2018.02.006","volume":"295","author":"Rani R.","year":"2018","unstructured":"Rani R, Dahiya S, Dhingra D. Improvement of antihyperglycemic activity of nano-thymoquinone in rat model of type-2 diabetes.","journal-title":"Chem Biol Interact"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.indcrop.2016.01.007","volume":"83","author":"Bitencourt P.E.","year":"2016","unstructured":"Bitencourt PE, Ferreira LM, Cargnelutti LO. A new biodegradable polymeric nanoparticle formulation containing Syzygium cumini: Phytochemical profile, antioxidant and antifungal activity and toxicity.","journal-title":"Ind Crops Prod"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.saa.2013.07.038","volume":"116","author":"Venkatachalam M.","year":"2013","unstructured":"Venkatachalam M, Govindaraju K, Sadiq AM. Functionalization of gold nanoparticles as antidiabetic nanomaterial.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=125","first-page":"188","volume":"13","author":"Shanker K.","year":"2017","unstructured":"Shanker K, Mohan GK, Hussain MA, Jayarambabu N, Pravallika PL. Green biosynthesis, characterization, antidiabetic activity, and investigational acute toxicity studies of some herbal-mediated silver nanoparticles on animal models.","journal-title":"Pharmacogn Mag"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"37158","DOI":"10.1039\/C7RA05693A","volume":"7","author":"Shanker K.","year":"2017","unstructured":"Shanker K, Naradala J, Mohan GK, Kumar G, Pravallika P. A sub-acute oral toxicity analysis and comparative anti-diabetic activity of zinc oxide, cerium oxide, silver nanoparticles, and Momordica charantia in streptozotocin-induced diabetic Wistar rats.","journal-title":"Rsc Adv"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/1753-0407.12554","volume":"10","author":"Prabhu S.","year":"2018","unstructured":"Prabhu S, Vinodhini S, Elanchezhiyan C, Rajeswari D. Evaluation of antidiabetic activity of biologically synthesized silver nanoparticles using Pouteria sapota in streptozotocin induced diabetic rats.","journal-title":"J Diabetes"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.sjbs.2015.06.026","volume":"24","author":"Malapermal V.","year":"2017","unstructured":"Malapermal V, Botha I, Krishna SBN, Mbatha JN. Enhancing antidiabetic and antimicrobial performance of Ocimum basilicum, and Ocimum sanctum (L.) using silver nanoparticles.","journal-title":"Saudi J Biol Sci"},{"key":"ref=129","first-page":"25","volume":"2","author":"Swarnalatha L.","year":"2012","unstructured":"Swarnalatha L, Rachela C, Ranjan P, Baradwaj P. Evaluation of antidiabetic activity of Sphaeranthus amaranthoides silver nanoparticles.","journal-title":"Int J Nanomater Biostruct"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bjp.2015.03.004","volume":"25","author":"Langle A.","year":"2015","unstructured":"Langle A, Gonz\u00e1lez-Coronel MA, Carmona-Guti\u00e9rrez G. Stevia rebaudiana loaded titanium oxide nanomaterials as an antidiabetic agent in rats.","journal-title":"Rev Bras Farmacogn"},{"key":"ref=131","first-page":"2108","volume":"5","author":"Bindu R.H.","year":"2014","unstructured":"Bindu RH, Lakshmi SM, Himaja N, Nirosha K, Pooja M. Formulation, characterisation and anti diabetic evaluation of talinum portulacifolium (forssk.) loaded solid lipid nanoparticles in streptozotocin","journal-title":"J Glob Trends Pharm Sci"},{"key":"ref=132","doi-asserted-by":"crossref","DOI":"10.4172\/2155-983X.1000152","volume":"7","author":"Kavitha K.","year":"2017","unstructured":"Kavitha K, Sujatha K, Manoharan S. Development, characterization and antidiabetic potentials of nilgirianthus ciliatus nees derived nanoparticles.","journal-title":"J Nanomedine Biotherapeutic Discov"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jconrel.2003.12.017","volume":"95","author":"Krauland A.H.","year":"2004","unstructured":"Krauland AH, Guggi D, Bernkop-Schn\u00fcrch A. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.","journal-title":"J Control Release"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-3659(95)00146-8","volume":"39","author":"Borchard G.","year":"1996","unstructured":"Borchard G, Lue\u00dfen HL, de Boer AG. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions","journal-title":"J Control Release"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1461-5347(00)00302-3","volume":"3","author":"Ward P.D.","year":"2000","unstructured":"Ward PD, Tippin TK, Thakker DR. Enhancing paracellular permeability by modulating epithelial tight junctions.","journal-title":"Pharm Sci Technol Today"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1042\/bst0051739","volume":"5","author":"Patel H.M.","year":"1977","unstructured":"Patel HM, Ryman BE. Orally Administered liposomally entrapped insulin.","journal-title":"Biochem Soc Trans"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/diab.37.2.246","volume":"37","author":"Damg\u00e9 C.","year":"1988","unstructured":"Damg\u00e9 C, Michel C, Aprahamian M, Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier.","journal-title":"Diabetes"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","volume":"117","author":"Damg\u00e9 C.","year":"2007","unstructured":"Damg\u00e9 C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.","journal-title":"J Control Release"},{"key":"ref=139","volume":"18","author":"Lin Y-H.","year":"2007","unstructured":"Lin Y-H, Chen C-T, Liang H-F. Novel nanoparticles for oral insulin delivery the paracellular pathway.","journal-title":"Nanotechnology"},{"key":"ref=140","first-page":"121","volume":"51","author":"Jindal S.K.","year":"2009","unstructured":"Jindal SK, Singh M, Goswami M. Formulation and evaluation of insulin enteric microspheres for oral drug delivery.","journal-title":"Acta Pharm Sci"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5455\/2319-2003.ijbcp20140405","volume":"3","author":"Woldu M.A.","year":"2014","unstructured":"Woldu MA, Lenjisa JL. Nanoparticles and the new era in diabetes management.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1096\/fj.04-2747rev","volume":"19","author":"Moghimi S.M.","year":"2005","unstructured":"Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects.","journal-title":"FASEB J"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1072-7515(01)01014-6","volume":"193","author":"Hanazaki K.","year":"2001","unstructured":"Hanazaki K, Nos\u00e9 Y, Brunicardi FC. Artificial endocrine pancreas.","journal-title":"J Am Coll Surg"},{"key":"ref=144","first-page":"85","volume":"7","author":"Subramani K.","year":"2012","unstructured":"Subramani K, Pathak S, Hosseinkhani H. Recent trends in diabetes treatment using nanotechnology.","journal-title":"Dig J Nanomater Biostruct"},{"key":"ref=145","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7439.1000137","volume":"3","author":"Rahiman S.","year":"2012","unstructured":"Rahiman S, Tantry BA. Nanomedicine current trends in diabetes management.","journal-title":"J Nanomed Nanotechnol"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T18:02:09Z","timestamp":1606672929000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170520\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":145,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,7,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450120666190307101642","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-11-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}